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Bone histology in incipient and advanced renal disease. Quantita-
tive bone histology (micromorphometry of undecalcified sections,
analysis under polarized light; fluorescence microscopy with tetracy-
cline double labelling) as well as serum and urinary chemistry
(creatinine clearance, parathyroid hormone, ionized Ca, bone
phosphatase, pH) were studied in 50 patients with incipient to
advanced (glomerular filtration rate, 80 to 6 mI/mm X 1.73 m2)
renal insufficiency. In incipient renal failure, indirect evidence of
parathyroid hormone excess was found in the skeleton (empty os-
teoclastic lacunae, woven osteoid). Osteoclastic surface resorption
was abnormally high when GFR fell below 50 ml/min X 1.73 m2
and endosteal fibrosis appeared below GFR of 30 mI/mm Xl.73
m2. With the tetracycline double-labelling technique, a miner-
alization defect was demonstrable in many but not all patients.
Histologie de l'os au cours de l'insuffisance rénale debutante et de
l'insuffisance rénale majeure. Chez 50 malades atteints d'insuffisance
rénale a des degrés divers (debit de filtration glomérulaire de
80 a 6 mI/mm. 1,73m2) ont été réalisés I'étude histologique quanti-
tative de l'os (micromorphométrie des coupes non déclacifiées,
analyse en lumière polarisée, microscopie en fluorescence après
double marquage par Ia tetracycline) ainsi que les determinations
de Ia clearance de Ia créatinine, du calcium ionisé, de l'hormone
parathyro'fdienne, des phosphatases osseuses et du pH. Au cours
de l'insuffisance rénale debutante on trouve des signes indirects
d'une augmentation de l'hormone parathyro'idienne a l'examen
de l'os (lacunes ostéoclastiques vides, osteolde lamellaire). La
surface de resorption osteoclastique est anormalement grande
le debit de filtration glomérulaire est inférieur a 50 mI/mm . 1,73
m2 et il apparaIt une fibrose dans les lacunes de resorption quand
ce debit est inférieur a 30 mI/mm X 1.73 m2. Un défaut de
minéralisation est mis en evidence par le double marquage par
Ia tetracycline chez beaucoup de malades mais non chez Ia totalité
d'entre eux.
Whereas the skeletal lesions of the terminal stage
of renal insufficiency are well known, skeletal histol-
ogy in early stages of renal insufficiency has not been
investigated to any large extent [1-4]. This is some-
what surprising, since cellular mechanisms leading to
abnormal bone histology can more easily be unra-
velled in a skeleton with incipient lesions rather than
in a skeleton with far-advanced lesions.
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Therefore, we investigated in a cross-sectional type
of study 50 patients with chronic renal disease at
various levels of glomerular filtration rate (GFR).
Evidence of fibroosteoclasis was found even in very
early renal failure: with the tetracycline double-label-
ing technique, defective mineralization was demon-
strable only in a fraction of the patients studied.
Methods
Patients. Fifty patients (19 male, 31 female) with
chronic renal disease (duration: one month to 7 yr)
who had presented themselves for diagnostic eval-
uation in the outpatient department were examined
(age: 43.2 11.3; range, 20 to 61 yr). The underlying
renal disease was glomerulonephritis (19/50), renal
malformation and or pyelonephritis (2 1/50), poly-
cystic disease (6/50), analgesic abuse, malignant
hypertension, Kimmelstiel-Wilson and unknown
etiology (one case each).
None of the patients had received treatment such
as vitamin D or analogous sterols or orally admin-
istered phosphate binders or calcium supplements.
For the histological study, 22 victims of traffic ac-
cidents without known skeletal or renal disease were
chosen as controls (12 male; 10 female;.age: 42.5
+ 15.2; range, 24 to 65 yr).
Bone histology. All patients were subjected to tet-
racycline double-labelling: they were given tetracy-
cline hydrochloride, 500 mg/24 hr, from day 18 to 16
and 4 to 0 prior to biopsy. Biopsy specimens were
taken from the iliac crest (4 cm behind the spina iliaca
anterior superior) with an electric drill [5]. The
specimens were fixed in alcohol, embedded in meth-
ylmethacrylate, cut (3 t) and stained with Mas-
son-Goldner as described previously [6, 7]. Micro-
morphometric measurements were performed by the
method of Merz and Schenk [8]; areas were measured
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by point counting and perimeter lengths by counting
intersections with semicircular sampling lines.
The following indexes were calculated: (1) vol-
umetric density of bone (Vv) indicating the fraction of
spongiosal volume occupied by bone matrix (%); (2)
volumetric density of osteoid (Vo) indicating the frac-
tion of spongiosal volume occupied by unmineralized
(lamellar or woven) osteoid (%); (3) surface density
(SD), i.e., endosteal (= trabecular) surface per unit
volume of spongy bone, indicating the size of the in
terface between bone tissue and marrow cavity
(mm2/cm3); (4) specific surface (S/V), the ratio of
trabecular surface to trabecular volume (mm2/mm5)
(this ratio falls as trabecular diameter rises); (5)
osteoid surface density (OS) indicating the size of un-
mineralized osteoid seams on the trabecular surface
per unit volume of spongy bone (mm2/mm3); (6)
osteoid surface fraction (OSF) indicating the fraction
trabecular surface covered by unmineralized osteoid
seams (%); (7) mean thickness of osteoid seams (S),
calculated as the ratio of absolute osteoid volume and
absolute osteoid surface; (8) osteoclastic resorption
surface (HO) indicating the fraction of mineralized
(= nonosteoid) trabecular surface covered by osteo-
clasts; (9) lacunae (L) indicating the fraction of
trabecular surface covered by inactive resorption cav-
ities (not filled with osteoclasts); and (JO) endosteal
fibrosis surface fraction (EOFS) indicating the fraction
of trabecular surface covered with layers of collagen
fibers.
In addition, all sections were analyzed under pola-
rized light; the fraction of osteoid seams exhibiting
nonlamellar warp-and-woof pattern (woven osteoid)
was counted (Fig. 1, a and b; 2, a and b). Unstained
sections (3 t) were analyzed by fluorescence micros-
copy [7]. "Mineralizing osteoid seams" were defined
as seams showing two distinct tetracycline bands
(Fig. 3); seams with homogenous fluorescence ("dif-
fuse staining") (Fig. 4) or with one band (slow miner-
alization with fusion of bands?) were counted as non-
mineralizing seams. Since woven osteoid usually,
though not invariably, fails to mineralize with a dis-
tinct mineralization front, osteoid recognizable as
woven osteoid was omitted when mineralizing os-
teoid seams were counted. The fraction of seams
showing a tetracycline double band (irrespective of its
extension) was counted. The concepts underlying this
technique have been discussed in more detail pre-
viously [7].
The normal range for mineralizing seams was de-
fined by studying biopsy specimens of ten non-
hyper.parathyroid renal stone formers labelled with
tetracycline. (Mineralization in this group appears
not to be grossly abnormal, although normalcy of
mineralization remains to be proven.)
Serum and urine chemistry. In fasting serum, Ca
and P concentrations and alkaline phosphatase activ-
ity were measured by autoanalyzer. None of the
patients had elevated serum transaminase values. Io-
nized serum Ca was measured with a flow-through
electrode (Orion, model 99-20) with a digital volt-
meter (model 701). Blood samples were obtained in
Vacutainers under anaerobic conditions and meas-
ured according to the method of Lindgarde [9]. Com-
mercial standards (Orion Co.) were used. The normal
range was 2.30 0.085 mEq/liter for female and 2.39
0.085 mEq/liter for male individuals.
Urinary hydroxyproline was measured according
to the method of Firschein and Schill [10].
Bone phosphatase in serum was measured after
electrophoretic separation on cellulose acetate (Siede
G, et a!: unpublished data). Parathyroid hormone
(PTH) was measured with a guinea pig antibody
against bovine PTH (normal range <220 pEq of
bovine PTH/ml) by the method of Lequin, Hack-
eng and Schopman [11].
Fig. 1. a, Undecalcified section of iliac crest spongiosa in a 40-year-old woman receiving maintenance hemodialysis (methylmetacrylate
embedding. Masson-Goldner stain. X304). Note the presence of a broad osteoid seam as seen under nonpolarized light. b, Same section under
polarized light. Note the presence of parallel lainellae in the osteoid seam. The regular spatial order of the lamellae reflects the supramolecular
order of collagen fibers.
Fig. 2. a, Undecalcified section of iliac crest spongiosa in a 21-year-old man receiving maintenance hemodialysis (met hylmetacrylate embedding,
X195). Under nonpolarized light, a broad unmineralized osteoid seam is seen in the right upper corner. In the center below, a broad zone is
seen which also consists of nonmineralized osteoid. The osteoid of these two structures, staining bright red with the Masson-Goldndr stain,
cannot be differentiated under nonpolarized light. B, Same section under polarized light. In the osteoid seam in the upper right corner, well-
delineated lamellae ("lamellar osteoid") can be recognized, whereas the osteoid in the center below exhibits a disordered "warp-and-woof'
pattern (woven osteoid).
Fig. 3. Undecalc (fled section of iliac crest spongiosa in a 23-year-old woman receiving maintenance hemodialysis (methylmetacrylate embedding,
unstained section, in vivo tetracycline labelling. X389). Two distinct bands with yellow fluorescence are visible in the osteoid seam. The lower
band corresponds to the first labelling period (2 days), the intermediate unstained band corresponds to the interval without labelling (12
days) and the broad seam on top corresponds to the second labelling period (4 days).
Fig. 4. Undecalcifled section of iliac crest spongiosa in a 40-year-old woman receiving maintenance hemodialysis (methylmetacrylate embedding.
unstainedsection, in vivo tetracycline labelling, X195). The osteoid seams visible in this section show only "diffuse staining". This indicates
that tetracycline is not actively incorporated into the mineralization front. Consequently, the two-band pattern (see Fig. 3) is not visible.
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Urinary Ca and P concentrations were measured
after 24-hr urine collection under ambulatory condi-
tions and without dietary restrictions. Completeness
of collection was controlled by measuring urine
creatinine. Creatinine clearance (urinary creatinine
measured according to the method of Popper, Man-
del and Mayer [12]) was used as a measure of GFR.
Statistical evaluation. The data were analyzed with
a computer (PDP-ll Digital Equipment). Group
differences were analyzed with Student's t test (the
values conformed to a normal distribution). The sig-
nificance of correlation was checked by calculating
the t values.
Results
Bone histology (Table 1). 1) Osteosclerosis, i.e., an
increase of the fraction of spongiosal volume repre-
sented by mineralized bone (Vv), was seen first in
individual patients with GFR <60 mI/mm X 1.73
m2. The 70th percentile of volumetric density was
exceeded in more than 50% of the patients at a GFR
of 40 mi/mm X 1.73 m2. At a GFR <20 mI/mm X
1.73 m2, the volumetric density was beyond the 95th
percentile in 4 of 13 patients. The increase of Vv
correlated with the accumulation of osteoid (Vo) (r =
0.43).
2) Accumulation of osteoid was demonstrated by
measuring the extent of trabecular surface covered by
osteoid seams (OS), the fraction of spongiosal volume
represented by unmineralized bone matrix (Vo) and
by calculating the average seam thickness (S). Osteoid
increased as renal function deteriorated, i.e., the in-
crease of OS correlated significantly with the fall of
GFR (r =
—0.6). In individual patients, values of OS
beyond the 95th percentile were already seen at a
GFR of 70 mI/mm X 1.73 m2; at a GFR of 50
mi/mm X 1.73 m2, OS exceeded the 95th percentile in
more than 50% of the patients. At a GFR <20
ml/min X 1.73 m2, OS was beyond the 95th percent.
ile in 12 of 13 patients.
Osteoid (OS) was correlated with osteoclastic sur-
face resorption (HO) (r = 0.79) and endosteal fi-
brosis (EOF) (r = 0.69) pointing to the tight coupling
between bone apposition and bone resorption. This
correlation is the more surprising, since accumulation
of osteoid, as a result of a mineralization defect,
should tend to obscure the correlation between re-
sorption indexes and osteoid.
The ratio of trabecular surface and trabecular vol-
ume (S/V) which is inversely related to trabecular
diameter, correlated with osteoid seam thickness (S)
(r = —0.5) suggesting that trabeculae are coarse as a
consequence of their osteoid coating [13]. Osteoid
(OS) increased as serum PTH levels rose (r = 0.62).
Since both OS and PTH rose as GFR fell, this corre-
lation might merely be fortuitous; however, it might
also reflect a rise of osteoid in the skeleton as turn-
over increases under the influence of PTH.
Osteoid volume (Vo) was loosely but significantly
correlated with the degree of metabolic acidosis (r =
—0.36).
3) Osteoclastic surface resorption (r = —0.6) in-
creased and endosteal fibrosis appeared as GFR fell.
In only 5 of 18 patients with a GFR>50 ml/min ><
1.73 2 osteoclastic surface resorption was beyond the
70th percentile. Patients in whom osteoclastic surface
resorption exceeded the 95th percentile were not seen
before GFR fell below 50 mI/mm >< 1.73 m2 and
endosteal fibrosis did not appear before GFR had
fallen below 30 ml/min X 1.73 m2. Osteoclastic sur-
face resorption was beyond the 95th percentile in
more than 50% of the patients with a GFR of 40
mI/mm X 1.73 m2; endosteal fibrosis was present in
virtually all (24 of 27) patients with a GFR < 30
mI/mm )< 1.73 m2. Although in early renal failure,
Table 1. Bone histology at various levels of glomerular filtration rate (GFR)'5
GFR
mi/mm X 1.73 m2
Vv
%
Vo
%
OSF
%
S SD
mm2/cm3
S/V
mm2/mm3
L
%
HO
%
EOFS
%
0-19 24.7 + 6.4 2.13 + 1.71 51 + 27 9.9 + 4.2 3871 + 511 14.6 4.9 23.2 + 4.4 4.5 + 2.2 6.6 + 4.9
(N = 13)
20-30 23.2 + 6.1 2.54 3.23 49 21 12.0 10.8 3726 + 644 15.8 * 3.5 21.8 + 6.1 4.8 3.6 5.0 6.1
(iv = 15)
40-59 21.0 + 5.1 0.80 + 0.60 22 13 9.5 4.2 3699 534 16.3 + 4.2 14.9 + 5.3 1.8 + 0.8 0
(N= 12)
60-117 17.0 + 3.8 0.23 + 0.23 14 * 11 6.2 + 3.3 2963 504 18 + 4.1 10.8 + 4.2 LI 0.8 0
(N = 10)
Normal controls 15.6 + 8.8 0.13 0.24 7.7 12 6.4 11 3124 1394 20.6 6.1 7.4 * 7.6 0.74 1.8 0
(N = 22)
OValues are given as + so except for normal controls where values are given as + 2 SD.
-
bVv = volumetric density of bone; Vo = volumetric density of osteoid; OSF = osteoid surface fraction; S = osteoid seam thickness; SD =
surface density; S/V = specific surface; L lacunar surface fraction; HO = osteoclastic resorption surface; EOFS = endosteal fibrosis.
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direct evidence of the action of PTH on the skeleton
(i.e., increased osteoclast counts) was rather in-
constant, indirect evidence of excess PTH activity was
seen even when osteoclast counts were not yet outside
of the normal range. These indirect signs were an
increase of empty lacunae (L) on the trabecular sur-
face (as evidence of past osteoclastic activity) and the
presence of woven osteoid. Even in early renal in-
sufficiency (GFR > 80 mI/mm >< 1.73 m2), woven
osteoid with disturbed collagen texture was seen fill-
ing up former osteoclastic lacunae. The presence of
woven osteoid is indicative of precipitous synthesis of
bone matrix by osteoblasts that are under the in-
fluence of excessive PTH concentrations.
Endosteal fibrosis (EOF) correlated better than
any other index with PTH (r = 0.76). This is in good
agreement with findings of Duursma et al [14] and
Mehls et al [15]. The correlation between HO and
PTH was much better when osteoclastic resorption
was related to nonosteoid surface, i.e., mineralized
trabecular surface (r = 0.63), than when osteoclastic
resorption was related to total trabecular surface (r =
0.42). This indicates that under the stimulus of PTH
the appearance of osteoclasts is related to the exten-
sion of mineralized rather than total trabecular sur-
face. This would support the concept that high local
Ca concentrations (which osteoid is unable to pro-
vide) are necessary to initiate osteoclastic resorption
[16].
The increase of the fraction of nonosteoid trabecu-
lar surface covered by osteoclastic resorption (HO)
showed some correlation with the fall of ionized se-
rum Ca (r =
—0.44). Obviously, osteoclastic surface
resorption is a PTH-mediated homeostatic effort to
bring serum Ca levels back into the normal range.
In patients with renal insufficiency, specific surface
—i.e., the ratio of trabecular surface to trabecular
volume (S/V)—was diminished, indicating an increase
of trabecular diameter. This finding is of interest in
view of the well-known coarse trabecular structure
that is commonly seen in skeletal roentgenograms.
4) Woven osteoid (Fig, 5). Woven osteoid, defined
by disordered collagen texture and by its character-
istic pattern of birefringence, was seen even in some
patients with GFR80 mI/mm X 1.73 m2. The frac-
tion of osteoid seams consisting of woven osteoid
rose as GFR fell. With falling GFR the extension of
woven osteoid over the trabecular surface rose pro-
gressively: at a GFR > 40 ml/min X 1.73 m2, woven
osteoid was only seen filling up circumscribed Ia-
cunae, whereas broad apposition fronts were always
of the lamellar variety. Broad osteoid seams of woven
collagen texture that extended over a considerable
fraction of the trabecular surface were not found
before GFR had dropped below approximately 30
mI/mm >< 1.73 m2.
5) Mineralization defect (Fig. 6). Although individ-
ual patients with GFR over 40 mI/mm X 1.73 m2 had
an increased fraction of nonlabelled osteoid seams,
patients with a severe mineralization defect were not
seen before GFR had fallen below 40 ml/min X 1.73
m2. Yet, it is remarkable that even in advanced renal
failure, mineralization may be perfectly normal, when
evaluated with the tetracycline double-labelling tech-
nique. Due to the limited number of observations,
it cannot be decided whether there is a correlation
between GFR and incidence of a mineralization de-
fect.
6) A bnormal histology with normal serum PTH con-
centrations. In 5 of 16 patients with normal serum
PTH (<220 pEq of bovine PTH/ml) with GFR <70
ml/min >< 1.73 m2, increased numbers of osteoclasts
were counted. Although technical or methodological
problems with PTH measurements can certainly not
be excluded, the finding may also indicate that single
PTH measurements are not representative for aver-
age serum PTH activity.
7) Correlation between renal pathology and bone
histology. There was no recognizable correlation be-
tween the nature of renal disease and the severity of
histologic lesions. It is our personal impression that at
any given level of GFR, bone disease is more pro-
nounced in patients with analgesic abuse; because of
the composition of the patient group in this study,
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Fig. 6. Fraction of mineralizing osteoid seams (tetracycline label-
ling) at various levels of GFR. ( X = no fronts.)
the hypothesis, unfortunately, could not be tested
directly.
Serum biochemistry as an indicator of bone his-
tology. 1) Serum calcium. As had been found by
Duursma et al [14] and Ritz et al [17], total serum Ca
(r =
—0.64) and ionized serum Ca (r = —0.69) fell as
the amount of osteoid (Vo) in the skeleton increased.
A similar correlation between serum Ca was also
found for surface fraction of osteoid (OSF) and mean
osteoid seam thickness (s). Osteoclastic surface re-
sorption increased as ionized serum Ca decreased (r
=
—0.44).
2) Serum alkaline phosphatase. Although serum al-
kaline phosphatase and specific bone phosphatase
were closely correlated (r = 0.94), the discrimination
between normal and abnormal bone histology was
better with the specific bone phosphatase. In patients
with abnormal bone histology, total bone alkaline
phosphatase was abnormal in 16% of the cases and
specific bone phosphatase was abnormal in 77% of
the cases. Both phosphatase values correlated equally
well with bone histology: the osteoblastic enzyme
alkaline phosphatase correlated not only with histo-
logic indicators of bone apposition—i.e., osteoid vol-
ume (r 0.76) and osteoid surface (r = 0.53)—but
also with histologic markers of bone resorption—i.e.,
with HO (r = 0.36)—and endosteal fibrosis (r =
0.58). This is presumably due to the fact that in bone
remodelling, apposition and resorption are coupled
processes.
Serum alkaline phosphatase correlated better with
total osteoid surface (r = 0.53) than with the surface
fraction of active osteoid, i.e., osteoid covered with
osteoblasts (r = 0.3). This discrepancy may be related
to the difficulty of identifying active osteoblasts in the
presence of woven osteoid, thus resulting in a large
variance for this index (figures therefore not given in
Table 1). It is also conceivable that nonendosteal cells
(i.e., osteocytes) in woven bone may secrete alkaline
phosphatase and thus vitiate the correlation.
3) Urinary Ca excretion. As GFR fell, urinary Ca
excretion decreased (r = 0.44). As shown by Licht-
witz and Parlier [18], a low urinary Ca concentration
was found even with very modest reductions ofGFR.
4) Urinary hydroxyproline. Total urinary hydroxy-
proline, an indicator of bone matrix turnover, did
not correlate at all with bone histology.
5) Metabolic acidosis. As found previously by
Cochran and Nordin [19], arterial pH correlated
slightly but significantly (r = —0.36) with osteoid
volume (Vo). One need not necessarily accept their
[19] conclusion, that metabolic acidosis is detrimen-
tal to osteoid mineralization. The correlation may
be fortuitous, since in advanced renal failure, pa-
tients tend to be in metabolic acidosis and to have
more osteoid at the same time; alternatively, the cor-
relation may reflect the well-known [20] tendency of
hyperparathyroid subjects to be in metabolic aci-
dosis.
6) Serum PTH concentrations. Fasting serum PTH
concentrations were increased (>220 pEq of bovine
PTH/ml) in I of 7 patients with GFR > 70 mI/rn in
X 1.73 M2 and in 26 of 42 patients with GFR < 70
ml/min X 1.73 m2. Serum PTH increased exponen-
tially with decreasing GFR (r =
—0.61). An inverse
relationship between ionized serum Ca and serum
PTH was found (r =
—0.54).
Serum PTH correlated with osteoid volume (r =
0.45) and osteoid surface (r 0.61), with osteoclastic
resorption (r = 0.63) and even better with endosteal
fibrosis (r = 0.76),
Discussion
Reiss, Canterbury and Kanter [21] were the first to
demonstrate elevated serum PTH concentrations in
incipient renal failure. The present study supplements
their data by showing that even in very early renal
failure, evidence of parathyroid overactivity can be
demonstrated in the skeleton. The number of os-
teoclasts becomes abnormal only in advanced renal
failure, presumably because their measurement is
subject to rather large statistical error [22]. Alter-
natively, diminished responsiveness of the skeleton to
the effect of PTH may be present [23, 24]. In spite
of the absence of frankly increased numbers of os-
teoclasts, the accumulation of empty resorption cav-
ities as well as the appearance of woven osteoid even
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in the earliest stages of renal insufficiency point to a
stimulatory effect of PTH in the skeleton. Since the
presence of woven osteoid is evidence of accelerated
deposition of bone, the presence of empty lacunae is
unlikely to be the consequence of delayed filling of
lacunae by osteoblasts.
Parathyroid hormone activates mesenchymal cells
on the trabecular surface and induces remodelling
processes of sequential character, bone apposition in
each remodelling site being preceded by bone resorp-
tion. Consequently, both resorption (HO) and appo-
sition (Vo, OS) indexes are elevated in advancing
renal failure secondary to the rise of PTH. Presum-
ably, more intense stimulation by PTI-I is required for
endosteal fibrosis, since it does not appear before
GFR is markedly lowered and PTH concentrations
are concomitantly elevated. Consequently, endosteal
fibrosis is an indicator of more advanced osteitis fi-
brosa.
Osteoblasts, which are under the influence of PTH,
no longer deposit collagen in ordered lamellae with
regular spatial orientation of collagen fibers, but in
an irregularly disordered "woven" pattern which can
be visualized under polarized light. As noted by Bin-
swanger et al [3] in a smaller series, woven osteoid
appears quite early in renal failure. Its appearance
accounts for several characteristic features of renal
osteodystrophy: nontrajectorial structure of bone on
a macroscopic level is caused by the loss of spatial
orientation of collagen fibers; structural insufficiency
(fractures; epiphyseal slipping) is the result of inferior
biomechanical qualities of woven bone [25] and un-
dermineralization of the skeleton is primarily the
consequence of incomplete mineralization of woven
bone.
Defective mineralization (i.e., osteomalacia), once
postulated to precede the development of osteitis
fibrosa [26], is not consistently demonstrable in renal
failure when the in vivo tetracycline labelling tech-
nique is used. However, this technique does pre-
sent problems in renal bone disease with high bone
turnover. Deposition of mineral in a discrete min-
eralization front and a defined temporal relationship
between bone matrix deposition and bone matrix
mineralization are both prerequisites for the tetracy-
cline double-labelling technique [7]. These prerequi-
sites, unequivocally shown in lamellar bone, may no
longer hold true in woven bone. Scanning electron
microscopy studies have shown that lamellar or wo-
ven collagen texture are not mutually exclusive [27].
Rather, in uremic individuals collagen texture may
show the complete spectrum of deterioration from
the regular spatial order of lamellar bone to the
complete structural anarchy of woven bone. Woven
osteoid does circumvent the mineralization block of
uremia and mineralizes, although incompletely, even
in the absence of vitamin D [28]. This might be one
explanation for the absence of a demonstrable miner-
alization defect in a certain number of the patients
examined. However, ultrastructural studies are re-
quired before a mineralization defect can definitively
be excluded in those patients in whom mineralization
was found to be normal with the in vivo labelling
technique.
If mineralization were truly normal in some pa-
tients, this would imply that renal insufficiency must
be associated with additional factors of unknown na-
ture for osteomalacia to occur.
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